AID Genomics

AID Genomics is a leading genomic research and development company focused on pioneering precision medicines for cancers and infectious diseases. Dedicated to advancing healthcare, AID Genomics delivers cutting-edge diagnostic solutions that enable proactive preventative strategies for healthy individuals and personalized treatment approaches for those facing cancer. By synergizing bioinformatics, next-generation sequencing, and artificial intelligence, AID Genomics aims to unlock the transformative potential of DNA, positioning itself at the forefront of precision medicine. The company's expertise also extends to addressing infectious diseases, supported by sales offices in key markets such as Japan, the US, and other Asian countries.

With a strong commitment to innovation and public health, AID Genomics was selected by the Israeli government's Ministry of Health in 2020 to establish, manage, and maintain seven specialized COVID-19 testing laboratories. These state-of-the-art facilities possess a current capacity of 100,000 tests per day, underscoring AID Genomics' pivotal role in combating the pandemic. AID Genomics is located at Primary: menachem plaut 10 Rehovot, hashfela 7670621, IL.

AID Genomics is committed to improving global health outcomes through advanced research and development. We invite the management of AID Genomics to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and expand their reach.